Rothschild & Co. Redburn Downgrades Danaher Corporation (DHR) to Hold, Reduces PT

​Danaher Corporation (NYSE:DHR) is one of the Best Forever Stocks to Invest In Now. On October 8, Ed Ridley from Rothschild & Co. Redburn downgraded Danaher Corporation (NYSE:DHR) from Buy to Hold, while also reducing the price target from $245 to $220.

​The firm noted that the company trades at a premium valuation (forward non-GAAP P/E ratio of 26.30). However, despite this premium valuation, the 2025 and 2026 growth outlook remains below the historic levels.

​Ridley believes that this valuation suggests that the company is returning to its historic growth levels in the life sciences market. However, he expressed concern regarding the limited visibility for the pace of recovery in China and the sustainability of diagnostic growth.

​Danaher Corporation (NYSE:DHR) is a global innovator in life sciences and diagnostics. It provides equipment, consumables, and services that support the research, development, and manufacturing of biological medicines.

While we acknowledge the potential of DHR to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than DHR and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.